Thyroid Hormone Synthesis Without Thyroglobulin.

IF 6.6 1区 医学 Q1 ENDOCRINOLOGY & METABOLISM
Thyroid Pub Date : 2026-04-01 Epub Date: 2026-03-09 DOI:10.1177/10507256261429120
Crystal Young, Xiaohan Zhang, Aaron P Kellogg, Tatiana L Fonseca, Kevin Pena, Alisa Beyzin, Xiao-Hui Liao, Annunziata G Cicatiello, Hao Zhang, Antonio C Bianco, Samuel Refetoff, Peter Arvan
{"title":"Thyroid Hormone Synthesis Without Thyroglobulin.","authors":"Crystal Young, Xiaohan Zhang, Aaron P Kellogg, Tatiana L Fonseca, Kevin Pena, Alisa Beyzin, Xiao-Hui Liao, Annunziata G Cicatiello, Hao Zhang, Antonio C Bianco, Samuel Refetoff, Peter Arvan","doi":"10.1177/10507256261429120","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Heterozygosity of genetically encoded misfolded mutant thyroglobulin (TG, the thyroid hormone protein precursor) occurs with a frequency estimated at 1-in-217 people worldwide, resulting in subclinical hypothyroidism that largely escapes medical detection. However, patients carrying biallelic <i>TG</i> mutation, when untreated, are frankly hypothyroid unless and until they develop a massive goiter. To date, TG is the only proven endogenous precursor protein for thyroid hormone synthesis in vertebrates. Our objective was to understand how homozygous expression of mutant TG protein that cannot undergo secretion to the iodination site in the thyroid follicle lumen can be compatible with patients or animal models ultimately achieving normal/near-normal circulating T4 and T3 levels. Notably, in both monoallelic and biallelic disease, dead thyrocytes have been reported in the lumen of thyroid follicles.</p><p><strong>Methods: </strong>We recently engineered mice with homozygous <i>Tg-KO</i>, making it possible to study circulating T4 and T3 in the complete absence of TG protein expression. We also employed immunoblotting methods to test for the presence of thyroidal T4-containing and T3-containing protein.</p><p><strong>Results: </strong>We found that, concomitant with goiter growth, animals completely lacking TG (like patients or animals with biallelic <i>TG</i> defect) are able to eventually normalize circulating T4 levels when their goiter has sufficiently enlarged, while maintaining serum T3 at ∼two-thirds normal levels throughout life. Very little T3-containing protein is synthesized in the thyroid glands of <i>Tg-KO</i> mice; however, T4-containing protein is synthesized on the ghosts of dead thyrocytes, with T3 generated from circulating T4 deiodination. Albeit inefficient, thyroidal T4-containing protein content is not appreciably different in the presence of homozygous mutant TG or in the complete absence of TG.</p><p><strong>Conclusions: </strong>Our data suggest that in biallelic TG mutation, thyroid stimulating hormone (TSH)-driven iodination underlies inefficient T4 formation derived from the iodoproteome of dead thyrocytes. In the presence of homozygous mutant TG or in the complete absence of TG, normalizing circulating T4 requires massive goiter growth to generate sufficient cells to sustain this inefficient hormonogenesis mechanism.</p>","PeriodicalId":23016,"journal":{"name":"Thyroid","volume":" ","pages":"441-450"},"PeriodicalIF":6.6000,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13184668/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Thyroid","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/10507256261429120","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/3/9 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Heterozygosity of genetically encoded misfolded mutant thyroglobulin (TG, the thyroid hormone protein precursor) occurs with a frequency estimated at 1-in-217 people worldwide, resulting in subclinical hypothyroidism that largely escapes medical detection. However, patients carrying biallelic TG mutation, when untreated, are frankly hypothyroid unless and until they develop a massive goiter. To date, TG is the only proven endogenous precursor protein for thyroid hormone synthesis in vertebrates. Our objective was to understand how homozygous expression of mutant TG protein that cannot undergo secretion to the iodination site in the thyroid follicle lumen can be compatible with patients or animal models ultimately achieving normal/near-normal circulating T4 and T3 levels. Notably, in both monoallelic and biallelic disease, dead thyrocytes have been reported in the lumen of thyroid follicles.

Methods: We recently engineered mice with homozygous Tg-KO, making it possible to study circulating T4 and T3 in the complete absence of TG protein expression. We also employed immunoblotting methods to test for the presence of thyroidal T4-containing and T3-containing protein.

Results: We found that, concomitant with goiter growth, animals completely lacking TG (like patients or animals with biallelic TG defect) are able to eventually normalize circulating T4 levels when their goiter has sufficiently enlarged, while maintaining serum T3 at ∼two-thirds normal levels throughout life. Very little T3-containing protein is synthesized in the thyroid glands of Tg-KO mice; however, T4-containing protein is synthesized on the ghosts of dead thyrocytes, with T3 generated from circulating T4 deiodination. Albeit inefficient, thyroidal T4-containing protein content is not appreciably different in the presence of homozygous mutant TG or in the complete absence of TG.

Conclusions: Our data suggest that in biallelic TG mutation, thyroid stimulating hormone (TSH)-driven iodination underlies inefficient T4 formation derived from the iodoproteome of dead thyrocytes. In the presence of homozygous mutant TG or in the complete absence of TG, normalizing circulating T4 requires massive goiter growth to generate sufficient cells to sustain this inefficient hormonogenesis mechanism.

不含甲状腺球蛋白的甲状腺激素合成。
背景:基因编码错误折叠突变甲状腺球蛋白(TG,甲状腺激素蛋白前体)的杂合性发生频率估计为全球每217人中有1人,导致亚临床甲状腺功能减退,在很大程度上逃避医学检测。然而,携带双等位基因TG突变的患者,在未经治疗的情况下,坦率地说,甲状腺功能低下,除非他们发展为巨大的甲状腺肿。迄今为止,TG是脊椎动物中唯一被证实的甲状腺激素合成的内源性前体蛋白。我们的目的是了解不能分泌到甲状腺滤泡腔碘化部位的突变TG蛋白的纯合表达如何与患者或动物模型兼容,最终达到正常/接近正常的循环T4和T3水平。值得注意的是,在单等位基因和双等位基因疾病中,在甲状腺滤泡腔中都有死亡的甲状腺细胞的报道。方法:我们最近用纯合子TG - ko改造小鼠,使研究完全没有TG蛋白表达的循环T4和T3成为可能。我们还采用免疫印迹法检测甲状腺含t4蛋白和含t3蛋白的存在。结果:我们发现,随着甲状腺肿的生长,完全缺乏TG的动物(如双等位基因TG缺陷的患者或动物)能够在甲状腺肿大时最终使循环T4水平正常化,同时终生将血清T3维持在正常水平的2 / 3。Tg-KO小鼠甲状腺中合成的含t3蛋白很少;然而,含T4蛋白是在死亡的甲状腺细胞的幽灵上合成的,T3是由循环的T4脱碘产生的。尽管效率不高,但在TG纯合突变体存在或TG完全不存在的情况下,甲状腺t4含蛋白含量没有明显差异。结论:我们的数据表明,在双等位基因TG突变中,促甲状腺激素(TSH)驱动的碘化可能导致死亡甲状腺细胞碘蛋白组生成T4的效率低下。在存在TG纯合突变体或完全不存在TG的情况下,循环T4的正常化需要大量甲状腺肿的生长来产生足够的细胞来维持这种低效的激素生成机制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Thyroid
Thyroid 医学-内分泌学与代谢
CiteScore
12.30
自引率
6.10%
发文量
195
审稿时长
6 months
期刊介绍: This authoritative journal program, including the monthly flagship journal Thyroid, Clinical Thyroidology® (monthly), and VideoEndocrinology™ (quarterly), delivers in-depth coverage on topics from clinical application and primary care, to the latest advances in diagnostic imaging and surgical techniques and technologies, designed to optimize patient care and outcomes. Thyroid is the leading, peer-reviewed resource for original articles, patient-focused reports, and translational research on thyroid cancer and all thyroid related diseases. The Journal delivers the latest findings on topics from primary care to clinical application, and is the exclusive source for the authoritative and updated American Thyroid Association (ATA) Guidelines for Managing Thyroid Disease.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书